Senolytic therapies suppress long COVID in human organoids … – BioWorld Online

Infection

Researchers from the University of Queensland discovered that senolytic therapies can suppress long-COVID neuropathology and long-term disorders caused by viral infections by reducing senescent cells, thereby reducing inflammation. Published Nov. 13, 2023, in Nature, the study examined the use of human pluripotent stem cells to generate small mini human brain organoids to screen for antiaging interventions called senolytics that selectively eliminate senescent cells that accumulate with age, lead author Julio Aguado told BioWorld.

Read the rest here:

Senolytic therapies suppress long COVID in human organoids ... - BioWorld Online

Related Posts